Lung Cancer Resection after Immunochemotherapy Versus Chemotherapy in Oligometastatic Nonsmall Cell Lung Cancer.

The Thoracic and cardiovascular surgeon(2023)

引用 3|浏览1
暂无评分
摘要
 Despite the small patient number and short-term results, the progression-free and overall survival in patients with OMD after local therapy for metastases and primary tumor resection following a neoadjuvant course of immunochemotherapy might be promising compared with chemotherapy.
更多
查看译文
关键词
nonsmall cell lung cancer,immunotherapy,immunochemotherapy,neoadjuvant therapy,oligometastatic disease
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要